NuGen Medical Devices Inc.
NGMD.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -175.10% | 19.43% | -254.19% | 199.29% | 116.80% |
| Total Depreciation and Amortization | 16.57% | 3.97% | 7.83% | -2.83% | -0.88% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 466.33% | -47.51% | 159.78% | -74.02% | -250.17% |
| Change in Net Operating Assets | 3.98% | -176.76% | 152.83% | 91.88% | -298.18% |
| Cash from Operations | 7.96% | -49.14% | 10.12% | 71.37% | -204.49% |
| Capital Expenditure | -128.15% | -42.82% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 75.00% | -- | -- | -- | 0.00% |
| Cash from Investing | -125.23% | -44.91% | -- | -- | -2,466.67% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -85.06% | 523.08% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -100.00% | -85.41% | -96.08% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.06% | -48.88% | -4.25% | 69.13% | -125.48% |